1. Home
  2. ZWS vs COGT Comparison

ZWS vs COGT Comparison

Compare ZWS & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zurn Elkay Water Solutions Corporation

ZWS

Zurn Elkay Water Solutions Corporation

HOLD

Current Price

$49.34

Market Cap

7.9B

Sector

Industrials

ML Signal

HOLD

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

HOLD

Current Price

$39.56

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZWS
COGT
Founded
1900
2014
Country
United States
United States
Employees
N/A
258
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
6.6B
IPO Year
2008
2018

Fundamental Metrics

Financial Performance
Metric
ZWS
COGT
Price
$49.34
$39.56
Analyst Decision
Buy
Strong Buy
Analyst Count
6
15
Target Price
$53.67
$36.21
AVG Volume (30 Days)
894.8K
2.9M
Earning Date
04-21-2026
05-06-2026
Dividend Yield
0.86%
N/A
EPS Growth
25.00
N/A
EPS
0.35
N/A
Revenue
$1,530,500,000.00
$7,871,000.00
Revenue This Year
$6.90
N/A
Revenue Next Year
$5.13
$1,733.58
P/E Ratio
$140.46
N/A
Revenue Growth
19.40
N/A
52 Week Low
$35.73
$9.13
52 Week High
$53.76
$43.73

Technical Indicators

Market Signals
Indicator
ZWS
COGT
Relative Strength Index (RSI) 51.00 73.49
Support Level $49.23 $37.54
Resistance Level $51.65 $40.62
Average True Range (ATR) 1.28 1.54
MACD 0.00 0.50
Stochastic Oscillator 28.24 92.31

Price Performance

Historical Comparison
ZWS
COGT

About ZWS Zurn Elkay Water Solutions Corporation

Zurn Elkay Water Solutions Corp is a growth-oriented, pure-play water management business that designs, procures, manufactures, and markets the broadest sustainable product portfolio of specification-driven water management solutions to improve health, hydration, human safety and the environment. Its product portfolio includes professional grade water safety and control products, flow systems products, hygienic and environmental products, and filtered drinking water products for public and private spaces that deliver superior value to building owners, positively impact the environment and human hygiene and reduce product installation time.

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Share on Social Networks: